Literature DB >> 29653253

Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis.

Yifeng Wang1, Wen-Xing Ding1, Tiangang Li2.   

Abstract

Liver is the major organ that regulates whole body cholesterol metabolism. Disrupted hepatic cholesterol homeostasis contributes to the pathogenesis of nonalcoholic steatohepatitis, dyslipidemia, atherosclerosis, and cardiovascular diseases. Hepatic bile acid synthesis is the major catabolic mechanism for cholesterol elimination from the body. Furthermore, bile acids are signaling molecules that regulate liver metabolism and inflammation. Autophagy is a highly-conserved lysosomal degradation mechanism, which plays an essential role in maintaining cellular integrity and energy homeostasis. In this review, we discuss emerging evidence linking hepatic cholesterol and bile acid metabolism to cellular autophagy activity in hepatocytes and macrophages, and how these interactions may be implicated in the pathogenesis and treatment of fatty liver disease and atherosclerosis.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Enterohepatic circulation; Hepatocyte; Hyperlipidemia; Liver injury; Macrophage; Nuclear receptor; Nutrient signaling

Mesh:

Substances:

Year:  2018        PMID: 29653253      PMCID: PMC6037329          DOI: 10.1016/j.bbalip.2018.04.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  105 in total

1.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

Authors:  K E Berge; H Tian; G A Graf; L Yu; N V Grishin; J Schultz; P Kwiterovich; B Shan; R Barnes; H H Hobbs
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

2.  Autophagy links inflammasomes to atherosclerotic progression.

Authors:  Babak Razani; Chu Feng; Trey Coleman; Roy Emanuel; Haitao Wen; Seungmin Hwang; Jenny P Ting; Herbert W Virgin; Michael B Kastan; Clay F Semenkovich
Journal:  Cell Metab       Date:  2012-03-20       Impact factor: 27.287

3.  Cholesterol depletion induces autophagy.

Authors:  Jinglei Cheng; Yuki Ohsaki; Kumi Tauchi-Sato; Akikazu Fujita; Toyoshi Fujimoto
Journal:  Biochem Biophys Res Commun       Date:  2006-10-16       Impact factor: 3.575

Review 4.  Future therapeutic directions in reverse cholesterol transport.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

Review 5.  Determinants of VLDL-triglycerides production.

Authors:  Søren Nielsen; Fredrik Karpe
Journal:  Curr Opin Lipidol       Date:  2012-08       Impact factor: 4.776

6.  Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease.

Authors:  Matthew J Elrick; Ting Yu; Chan Chung; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2012-08-07       Impact factor: 6.150

7.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Authors:  S Fazio; A S Major; L L Swift; L A Gleaves; M Accad; M F Linton; R V Farese
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

8.  Hepatic overexpression of cholesteryl ester hydrolase enhances cholesterol elimination and in vivo reverse cholesterol transport.

Authors:  Bin Zhao; Jingmei Song; Shobha Ghosh
Journal:  J Lipid Res       Date:  2008-07-03       Impact factor: 5.922

9.  FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.

Authors:  Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

10.  Targeting the Enterohepatic Bile Acid Signaling Induces Hepatic Autophagy via a CYP7A1-AKT-mTOR Axis in Mice.

Authors:  Yifeng Wang; Yifeng Ding; Jibiao Li; Hemantkumar Chavan; David Matye; Hong-Min Ni; John Y L Chiang; Partha Krishnamurthy; Wen-Xing Ding; Tiangang Li
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-10-22
View more
  11 in total

Review 1.  ATF3 in atherosclerosis: a controversial transcription factor.

Authors:  Bingyu Wang; Xi Yang; Xinyi Sun; Jianhui Liu; Yin Fu; Bingyang Liu; Jun Qiu; Jiangfang Lian; Jianqing Zhou
Journal:  J Mol Med (Berl)       Date:  2022-10-08       Impact factor: 5.606

Review 2.  The role of lactoferrin in atherosclerosis.

Authors:  Cailong Chen; Menglan Lu; Zheng Zhang; Liqiang Qin
Journal:  Biometals       Date:  2022-09-02       Impact factor: 3.378

3.  Gut Parabacteroides merdae protects against cardiovascular damage by enhancing branched-chain amino acid catabolism.

Authors:  Shanshan Qiao; Chang Liu; Li Sun; Tao Wang; Huanqin Dai; Kai Wang; Li Bao; Hantian Li; Wenzhao Wang; Shuang-Jiang Liu; Hongwei Liu
Journal:  Nat Metab       Date:  2022-10-17

Review 4.  Lipid Droplet Formation and Lipophagy in Fatty Liver Disease.

Authors:  Ryan J Schulze; Mark A McNiven
Journal:  Semin Liver Dis       Date:  2019-04-30       Impact factor: 6.115

Review 5.  Therapeutic regulation of autophagy in hepatic metabolism.

Authors:  Katherine Byrnes; Sophia Blessinger; Niani Tiaye Bailey; Russell Scaife; Gang Liu; Bilon Khambu
Journal:  Acta Pharm Sin B       Date:  2021-07-28       Impact factor: 11.413

6.  Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids.

Authors:  Xunxun Feng; Guangyao Zhai; Jiaqi Yang; Yang Liu; Yujie Zhou; Qianyun Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-05       Impact factor: 5.555

7.  Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention.

Authors:  Defeng Pan; Shengjue Xiao; Yue Hu; Qinyuan Pan; Qi Wu; Xiaotong Wang; Qiaozhi Liu; Ailin Liu; Jie Liu; Hong Zhu; Yufei Zhou
Journal:  Cardiovasc Ther       Date:  2021-12-13       Impact factor: 3.023

8.  Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis.

Authors:  Gulisudumu Maitiabula; Feng Tian; Peng Wang; Li Zhang; Xuejin Gao; Songlin Wan; Haifeng Sun; Jianbo Yang; Yupeng Zhang; Tingting Gao; Bin Xue; Chaojun Li; Jieshou Li; Xinying Wang
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-05-26

Review 9.  Autophagy in liver diseases: A review.

Authors:  Hui Qian; Xiaojuan Chao; Jessica Williams; Sam Fulte; Tiangang Li; Ling Yang; Wen-Xing Ding
Journal:  Mol Aspects Med       Date:  2021-06-11

Review 10.  Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD).

Authors:  Dyonne Y Vos; Bart van de Sluis
Journal:  Mol Metab       Date:  2021-01-05       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.